Research Article

Related GMR Articles

11/29/2011
Gene polymorphism; Meta-analysis; p53 codon 72; Prostate cancer

We examined whether p53 codon 72 polymorphism confers prostate cancer risk by conducting a meta-analysis. Two investigators independently searched the Pubmed, Embase and CBM databases. This meta-analysis was made of seven case-control studies, that included 892 prostate cancer cases and 1020 healthy controls. Meta-analysis results based on all the studies showed no significant association ... more

M.S. Li; J.L. Liu; Y. Wu; P. Wang; H. Teng
08/17/2010
Bladder cancer; Gene polymorphism; Meta-analysis; p53 codon 72

Although there have been many studies investigating a possible association between p53 codon 72 polymorphism and risk of bladder cancer, the results have been inconsistent. We conducted a meta-analysis of six epidemiological studies, which included 597 bladder cancer cases and 731 controls. Patients with bladder cancer had a significantly lower frequency of Pro/Arg [odds ratio (OR) = 0.80 ... more

D.B. Li; X. Wei; L.H. Jiang; Y. Wang; F. Xu
01/08/2014
Gene polymorphism; Head and neck carcinomas; Meta-analysis; p53 codon 72

Genetic factors have been shown to play a role in the development of head and neck cancers (HNCs). However, studies investigating the association between the TP53 Arg72Pro polymorphism and HNCs susceptibility have yielded conflicting results. Hence, we performed a meta-analysis of all eligible studies (up to January 1, 2012) to derive a more precise estimation of this association ... more

W.H. Ren; D.K. Jiang; Y. Pei; S.Q. Wang; X.M. Yang; L. Yu
12/19/2013
Aptamer; Nasopharyngeal carcinoma; SELEX

To screen the nucleic acid aptamers of the EB virus-positive nasopharyngeal carcinoma cells, we used SELEX technology and synthesized in vitro a 78-nucleotide random DNA library. We used normal nasopharyngeal epithelial cells and EB virus-positive low differentiated nasopharyngeal carcinoma cells as target to conduct 10 cycles of screening, cloning, sequencing, and identification ... more

W.X. Chen; K.H. Zhang; X.S. Zou; Y.Q. Chen; J.G. Li
12/19/2012
CNE2 cell line; Nasopharyngeal carcinoma; Sexual dimorphism; STGC3

STGC3 is a potential tumor suppressor in nasopharyngeal carcinoma. We previously found that CNE2 cells that re-expressed STGC3 formed smaller tumors in female mice than in male mice. Here, we investigated the sexual dimorphism of STGC3 as a tumor-suppressor in female and male nude mice injected subcutaneously with pcDNA3.1(+)-STGC3/CNE2 cells. ER-α was ... more

Q. Qiu; B. Hu; Z.C. Chen; X.S. He
02/14/2014
Cyclin D1; Nasopharyngeal carcinoma; Survivin

The association between cyclin D1 and survivin protein expressions with radiotherapy sensitivity in patients with nasopharyngeal carcinoma was investigated. Biopsy specimens of 72 patients with nasopharyngeal carcinoma were collected before the initiation of radiotherapy (49 cases were in the radiation-sensitive group and 23 cases were in the radiation-insensitive group). Conventional ... more

S.M. Fu; M.X. Xu; S.M. Lin; Z. Liang; J.H. Cai
03/17/2014
BiCAT; Co-expression networks; Nasopharyngeal carcinoma; Two-way clustering

This study sought to identify and characterize the function of genes as diagnostic markers for Epstein-Barr virus (EBV)-related nasopharyngeal cancer (NPC). The gene expression profile of GSE13597 was downloaded from the Gene Expression Omnibus database, which included 28 EBV-related NPC gene expression profile data sets, 25 disease samples, and 3 control samples. Data were pre-processed ... more

F. Chen; J. Liu; M. Fan; X.M. Wei; Y.L. Xie; L.H. Wang; H. Yang
05/29/2015
Concurrent chemoradiotherapy; Curative effect; Overall survival; Excision repair cross-complementing gene 1 (ERCC1); Nasopharyngeal carcinoma

In this study, the expression of DNA excision repair cross-complementing gene 1 (ERCC1) in local advanced nasopharyngeal carcinoma has been correlated with the efficacy of concurrent chemoradiotherapy. A total of 76 patients diagnosed with undifferentiated nasopharyngeal carcinoma diagnosed by nasopharyngeal biopsy and undergoing single-agent cisplatin chemotherapy (80 mg/m2) with ... more

R. Liang; Y. Lin; Z.H. Liu; X.L. Liao; C.L. Yuan; S.N. Liao; Y.Q. Li
03/30/2015
Gene silencing; Nasopharyngeal carcinoma; siRNA; Survivin

We examined the function of survivin gene expression in patients with nasopharyngeal carcinoma (NPC), as well as small interfering RNA (siRNA) on controlling CNE-2 NPC proliferation and apoptosis. Immunohistological methods, in situ hybridization, and reverse transcription-polymerase chain reaction technique were used to detect survivin protein and mRNA expression. We designed ... more

S.M. Fu; Z.H. Tu; L.Q. Deng; J.H. Cai; Z. Liang; Z.Q. Lin; Y.T. Wang
10/31/2014
Clinical outcome; Hepatocellular carcinoma; Polymorphism; Vascular endothelial growth factor

We conducted a cohort study to investigate the prognostic significance of vascular endothelial growth factor (VEGF) polymorphisms in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE). In total, 156 patients with histologically confirmed HCC within 2 months were collected from January 2007 to January 2008. The genotypes of VEGF-2578C/A ... more

J. Song; L.Z. Wang; X. Li; T.P. Jiang; T.Z. An; M. Xu; X.P. Wu; S. Zhou

Pages